Prediction of intestinal drug absorption properties by three-dimensional solubility parameters

被引:100
作者
Breitkreutz, J [1 ]
机构
[1] Univ Munster, Inst Pharmaceut Technol, D-4400 Munster, Germany
关键词
Hansen solubility parameters; regional gastrointestinal uptake; sustained-release dosage forms; site-specific delivery; passive diffusion; carrier-mediated transport;
D O I
10.1023/A:1011941319327
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose, The purpose of this study was to investigate the use of solubility parameters for the prediction of gastrointestinal absorption sites and absorption durations of drugs. Methods. Three-dimensional solubility parameters of drug substances were calculated using an advanced parameter set based on the group contribution methods of Fedors and Van Krevelen/Hoftyzer. The results of the calculations were illustrated via Bagley diagram and related to absorption data reported in the literature. Results. Solubility parameters of drugs which are known to be absorbed over a lone period in human's digestive tract were found in a limited area within the Bagley diagram. From the three-dimensional solubility parameters of these substances, a region for optimal absorption with the centre coordinates delta(v) = 20.3 (J . cm(-3)0.5) and delta(h) = 11.3 (J . cm(-3))(0.5) could be derived. Drugs with absorption sires along the whole gastrointestinal tract were found in this area. Drugs which are preferably absorbed from upper parts of the intestine are located in another typical region with partial solubility parameters delta(h) of more than 17 (J . cm(-3))(0.5). Conclusions. The method which is presented in this paper appears as a simple but effective method to estimate the absorption behaviour of new substances in drug research and development.
引用
收藏
页码:1370 / 1375
页数:6
相关论文
共 30 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
[Anonymous], LIPOPHILICITY DRUG A
[3]  
BAGLEY EB, 1971, J PAINT TECHNOL, V43, P35
[4]   DIFFERENTIAL ABSORPTION OF AMOXICILLIN FROM THE HUMAN SMALL AND LARGE-INTESTINE [J].
BARR, WH ;
ZOLA, EM ;
CANDLER, EL ;
HWANG, SM ;
TENDOLKAR, AV ;
SHAMBUREK, R ;
PARKER, B ;
HILTY, MD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (03) :279-285
[5]   SOLUBILITY PARAMETERS [J].
BARTON, AFM .
CHEMICAL REVIEWS, 1975, 75 (06) :731-753
[6]   A NEW METHOD FOR THE ESTIMATION OF THE AQUEOUS SOLUBILITY OF ORGANIC-COMPOUNDS [J].
BODOR, N ;
HUANG, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (09) :954-960
[7]  
BREITKREUTZ J, UNPUB COMPUTER PROGR
[8]   THE ABSORPTION OF PIRETANIDE FROM THE GASTROINTESTINAL-TRACT IS SITE-DEPENDENT [J].
BROCKMEIER, D ;
GRIGOLEIT, HG ;
LEONHARDT, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (01) :79-82
[9]   CLINICAL PHARMACOKINETICS OF ANTI-PARKINSONIAN DRUGS [J].
CEDARBAUM, JM .
CLINICAL PHARMACOKINETICS, 1987, 13 (03) :141-178
[10]   RELATIONSHIP BETWEEN THE RATE OF APPEARANCE OF OXPRENOLOL IN THE SYSTEMIC CIRCULATION AND THE LOCATION OF AN OXPRENOLOL OROS 16/260 DRUG DELIVERY SYSTEM WITHIN THE GASTROINTESTINAL-TRACT AS DETERMINED BY SCINTIGRAPHY [J].
DAVIS, SS ;
WASHINGTON, N ;
PARR, GD ;
SHORT, AH ;
JOHN, VA ;
LLOYD, P ;
WALKER, SM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (04) :435-443